Medical Mycology

Papers
(The H4-Index of Medical Mycology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19)62
On the lineage of Aspergillus fumigatus isolates in common laboratory use60
CHROMagarTM Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris53
General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation31
Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group30
Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification29
COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City25
Ebselen and diphenyl diselenide against fungal pathogens: A systematic review24
High detection rate of azole-resistantAspergillus fumigatusafter treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low 23
Emerging and future strategies in the management of recalcitrant Candida auris22
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients22
Filamentous growth is a general feature of Candida auris clinical isolates21
Clinical characteristics and risk factors for COVID-19-associated Candidemia21
C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan20
Candida tropicalis RON1is required for hyphal formation, biofilm development, and virulence but is dispensable for N-acetylglucosamine catabolism18
A review of recent research on antifungal agents against dermatophyte biofilms18
Aspergillosis: Emerging risk groups in critically ill patients18
Central nervous system candidiasis beyond neonates: Lessons from a nationwide study17
Farnesol: An approach on biofilms and nanotechnology17
0.053637027740479